Omalizumab boosts tolerance to multiple food allergies, study finds
News-Medical.Net | Drug Trial News
by
2d ago
A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option ..read more
Visit website
Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients
News-Medical.Net | Drug Trial News
by
2d ago
In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer ..read more
Visit website
Off-the-shelf cancer vaccine shows promising results in patients with KRAS-mutated tumors
News-Medical.Net | Drug Trial News
by
6d ago
Samara Rahman, 74, considers herself lucky. She gets to take walks on the beach, go swimming and ride her bike -; all things that were taken from her when she was diagnosed with pancreatic cancer in November of 2022 ..read more
Visit website
Study: Early advanced therapy significantly improves Crohn's disease outcomes
News-Medical.Net | Drug Trial News
by
6d ago
A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve outcomes, including by reducing the number of people requiring urgent abdominal surgery for treatment of their disease by ten-fold ..read more
Visit website
Innovative treatment increases survival of people with malignant mesothelioma, trial shows
News-Medical.Net | Drug Trial News
by
1w ago
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London ..read more
Visit website
Combination therapy shows promise in targeting latent HIV reservoirs
News-Medical.Net | Drug Trial News
by
1w ago
Antiretroviral therapies (ART) stop HIV replication in its tracks, allowing people with HIV to live relatively normal lives ..read more
Visit website
Novel three-drug combo shows promise in advanced HER2-negative breast cancer treatment
News-Medical.Net | Drug Trial News
by
1w ago
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center ..read more
Visit website
Combination therapy offers breakthrough in NSCLC treatment
News-Medical.Net | Drug Trial News
by
2w ago
A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from The University of Texas MD Anderson Cancer Center ..read more
Visit website
Drug repurposing study finds lonafarnib effective against RSV
News-Medical.Net | Drug Trial News
by
2w ago
A study in Nature Communications identifies lonafarnib from the ReFRAME drug-repurposing library as a potent inhibitor of the RSV fusion protein, showing promise in reducing RSV infection in vitro and in vivo ..read more
Visit website
Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients
News-Medical.Net | Drug Trial News
by
2w ago
A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor has anti-tumour effects in estrogen receptor positive breast cancer patients ..read more
Visit website

Follow News-Medical.Net | Drug Trial News on FeedSpot

Continue with Google
Continue with Apple
OR